Nonenzymatically glycated albumin (Amadori adducts) enhances nitric oxide synthase activity and gene expression in endothelial cells

Kidney International

Volumn 51, Issue 1, 1997, Pages 27-35

  Amore, Alessandro ^a,b   Cirina, Paola ^a   Mitola, Stefania ^a   Peruzzi, Licia ^a   Gianoglio, Bruno ^a   Rabbone, Ivana ^a   Sacchetti, Carla ^a   Cerutti, Franco ^a   Grillo, Caterina ^a   Coppo, Rosanna ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b REGINA MARGHERITA CHILDREN S HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED ALBUMIN; ICOSANOID; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 8044247807     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.4     Document Type: Article

References (51)

1. US RENAL DATA SYSTEM: USRDS 1992 Annual Data Report. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive Kidney Diseases, 1992
2. WOLF G, SHARMA K, CHEN Y, ERICKSEN M, ZIVADEH FN: High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-β. Kidney Int 42:647-656, 1992
3. LORENZI M, CAGLIERO E, TOLEDO S: Glucose toxicity for human endothelial cells in culture: Delayed replication, disturbed cell cycle, and accelerated death. Diabetes 34:621-627, 1985
4. HANEDA M, KIKKAWA R, HORIDE N, TOGAWA M, KOYA D, KASIWARA N, OOSHIMA A, SHIGETA Y: Glucose enhanced type IV collagen production in cultured mesangial cells. Diabetologia 34:198-200, 1991
5. AYO SH, RADNIK GA, GARONI JA, GLASS WF, KREISBERG JI: High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells. Am J Physiol 260:F185-F191, 1991
6. KIKKAWA R, UREMURA K, HANEDA M, ARIMURA T, EBATA K, SHIGETA Y: Evidence for the existence of polyol pathway in cultured rat mesangial cells. Diabetes 36:240-243, 1987
7. YAMAMOTO T, NAKAMURA T, NOBLE NA, RUOSLAHTI E, BORDER W: Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 90:1814-1818, 1993
8. MAKITA Z, RADOFF S, RAYFIELD EJ, YANG Z, SKOLNIK E, DELANEY V, FRIEDMAN EA, CERAMI A, VLASSARA H: Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 325:836-842, 1991
9. PREDESCU D, SIMIONESCU M, SIMIONESCU N, PALADE G: Binding and transcytosis by the microvascular endothelium of the murine myocardium: Evidence that glycoalbumin behaves as a bifunctional ligand. J Cell Biol 107:1729-1738, 1988
10. COHEN MP, ZIYADEH FN: Amadori glucose adducts modulate mesangial cell growth and collagen gene expression. Kidney Int 45:475-484, 1995
11. COHEN MP: Diabetes and Protein Glycosylation: Measurement and Biologic Relevance. New York, Springer Verlag, 1986
12. BROWNLEE M, CERAMI A, VLASSARA H: Adavenced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315-1321, 1988
13. GUHROW CE, MORRIS MA, DAY JF, THORPE SR, BAYNES J: Enhanced non enzymatic glucosylation of serum albumin in diabetes mellitus. Proc Natl Acad Sci USA 76:4258-4261, 1979
14. BROWNLEE M, VLASSARA H, CERAMI A: Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann Intern Med 101:527-537, 1984
15. NJOROGE FG, MONNIER VM: The chemistry of the Maillard reaction under physiological conditions: A review. Prog Clin Biol Res 304:85-107, 1989
16. LEDL F, BECK J, SENGL M, OSIANDER H, ESTENDORFER S, SEVERIN T, HUBER B: Chemical pathways of the Maillard reaction. Prog Clin Biol Res 304:23-42, 1989
17. MONNIER VM, WISHWANATH V, FRANK KE, ELMETS CA, DAUCHOT P, KOHN RR: Relation between complications of Type I diabetes mellitus and collagen-linked fluorescence. N Engl J Med 314:403-408, 1986
18. MONNIER VM, KOHON RR, CERAMI A: Accelerated age-related browning of human collagen in diabetes mellitus. Proc Natl Acatl Sci USA 81:583-587, 1984
19. SCHNIDER SL, KOHN RR: Glucosylation of human collagen in aging and diabetes mellitus. J Clin Invest 66:1179-1181, 1980
20. DAY JF, INGELBRETSEN WR, BAYNES JW, THORPE SR: Nonenzymatic glycosylation of serum proteins and hemoglobin: Response to changes in blood glucose levels in diabetic rats. Diabetes 29:524-527, 1980
21. COHEN MP, HUD E, WU VY: Amelioration of diabetic nephropathy by treatment with monoclonal antibodies against glycated albumin. Kidney Int 45:1673-1679, 1994
22. COHEN MP, HUD E: Production and characterization of monoclonal antibodies against human glycoalbumin. J Immunol Meth 117:121-129, 1989
23. BROCHNER-MORTENSEN J: Glomerular filtration rate and extracellular fluid volumes during normoglycemia and moderate hyperglycemia in diabetes. Scand J Clin Lab Invest 32:311-316, 1973
24. HOSTETTER TH, TROY JL, BRENNER BM: Glomerular hemodinamics in experimental diabetes. Kidney Int 19:410-415, 1981
25. HOSTETTER TH, RENNKE HG, BRENNER BM: The case of intrarenal hypertension in the initiation and progression of diabetic and other giomerulopathies. Am J Med 72:375-380, 1982
26. SABHATINI M, SANSONE G, UCCELLO F, GILIBERTI A, CONTE G, ANDREUCCI VE: Early glycosylation products induce glomerular hypertiltration in normal rats. Kidney Int 42:875-881, 1992
27. MONCADA S, PALMER RMJ, HIGGS EA: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142, 1991
28. BANK N, AYNEDJIAN HS: Role of EDRF (nitric oxide) in diabetic renal hyperfiltration. Kidney Int 43:1306-1312, 1993
29. BUCALA R, TRACEY KJ, CERAMI A: Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilation in experimental diabetes. J Clin Invest 87:432-438, 1991
30. HASEGAWA G, NAKANO K, SAWADA M, UNO K, SHIBAYAMA Y, IENAGA K, KONDO M: Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy. Kidney Int 40:1007-1012, 1991
31. BLUTLER B, CERAMI A: Cachectin: More than tumor necrosis factor. N Engl J Med 316:379-385, 1987
32. BUSSOLINO F, DE ROSSI M, SICA A, COLOTTA F, WANG JM, BOCCHIETTO E, PADURA IM, BOSIA A, DEJAND E, MANTOVANI A: Murine endothelioma cell lines transformed by polyoma middle T oncogene as target for and producers of cytokines. J Immunol 147:2122-2129, 1993
33. WILLIAMS RL, COURTNEIDGE SA, WAGNER EF: Embryonic lethalities and endothelial tumors in chimeric mice expressing polyoma virus middle T oncogene. Cell 52:121-131, 1988
34. GARLANDA C, PARRAVICINI C, SIRONO M, DE ROSSI M, WAINSTOK DE, CALAMANOVICI R, CAROZZI F, BUSSOLINO F, COLOTTA F, MANTOVANI A, VECCHI A: Progressive growth in immunodeficient mice and host cell recruitment hy mouse endothelial cells transformed by polyoma middle T: Implications for the pathogenesis of opportunistic tumors. Proc Natl Acad Sci USA 91:7291-7295, 1994
35. JAFFE EA, NACHMAN RL, BECKER CG, MINIK CR: Culture of human endothelial cells derived from umbilical vein. J Clin Invest 52:2745-2756, 1973
36. BROWNLEE M, VLASSARA A, KOONEY A, ULRICH P, CERAMI A: Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 232:1629-1632, 1986
37. XIE QW, CHO HJ, CALAYCAY, MUMFORD RA, SWIDEREK TD, LEE TD, DING A, TROSO T, NATHAN CJ: Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256:225-228, 1992
38. GROSS SS: Nitric oxide: Pathophysiological mechanisms. Annu Revu Physiol 57:737-769, 1995
39. COHEN MP, HUD E: Measurement of plasma glycoalbumin levels with a monoclonal antibody based ELISA. J Immunol Meth 122:279-283, 1989
40. STUEHIR DJ, GRIFFITH OW: Mammalian nitric oxide synthases. Adv Enzymol 65:287-346, 1992
41. STAMLER JS, SINGEL DJ, LOSCALZO J: Biochemistry of nitric oxide and its redox-activated forms. Science 258:1898-1902, 1992
42. POU S, POU WS, BREDT DS, SNYDER SH, ROSEN GM: Generation of superoxide by purified brain nitric oxide synthase. J Biol Chem 267:24173-24176, 1992
43. RAIJ L, BAYLIS C: Glomerular actions of nitric oxide. Kidney Int 48:20-32, 1995
44. TESFAMARIAN B, BROWN ML, DEYKIN D, COHEN RA: Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta. J Clin Invest 85:929-932, 1990
45. WEIDMANN P, BERETTA-PICCOLO C, TROST BN: Pressor factors and responsiveness in hypertension accompanayng diabetes mellitus. Hypertension 7-II:33-42, 1985
46. DERUBERTIS FR, CRAVEN PA: Activation of protein Kinase C in glomerular cells in diabetes. Mechanisms of potential links to the pathogenesis of diabetic glomerulopathy. Diabetes 43:1-8, 1993
47. DE RUBERTIS FR, CRAVEN PA: Eicosanoids in the pathogenesis of the functional and structural alterations of the kideny in diabetes. Am J Kidney Dis 22:727-735, 1993
48. MAUER SM, STEFFES MW, ELLIS EN, SUTHERLAND DER, BROWN DM, GOETZ FC: Structural-functional relationship in diabetic nephropathy. J Clin Invest 74:1143-1155, 1984
49. COHEN MP, HUD E, WU VY, ZIYADEH FN: Glycated albumin modified by Amadori adducts modulates aortic endothelial cell biol-ogy. Mol Cell Biochem 143:73-79, 1995
50. COHEN MP, SHARMA K, JIN Y, WU VY, TOMASZEWSKI J, ZIYADEH FN: Prevention of Diabetic nephropathy in db/db mice with glycated albumin antagonists. A novel treatment strategy. J Clin Invest 95: 2338-2345, 1995
51. PFEILSCHIFTER J, PIGNAT W, VOSBEK K, MARKI F: Interleukin 1 and tumor necrosis factor synergistically stimulate prostaglandin synthesis and pkhospholipase A2 release from rat renal mesangial cells. Biochem Biophys Res Commun 159:385-394, 1989